KVH Industries, Inc. (NASDAQ: KVHI) Earnings Report Highlights

Posted Mar 7 by John Deo

Earnings per Share (EPS) fell short at -$0.22 compared to the estimated -$0.07. Total revenues decreased by 1

Source: Two Blokes Trading

Merck KGaA's Financial Overview and Market Position

Posted Mar 7 by John Deo

Merck KGaA (PNK:MKGAF) reported earnings per share of $2.14, missing estimates. The company's revenue was $5.

Source: Two Blokes Trading

Tivic Health Systems, Inc. (NASDAQ:TIVC) Executes Reverse Stock Split

Posted Mar 7 by John Deo

Tivic Health Systems, Inc. (NASDAQ:TIVC) has conducted a reverse stock split at a ratio of 17 for 1 to meet N

Source: Two Blokes Trading

Aytu BioPharma, Inc. (NASDAQ:AYTU) and Its Competitive Landscape

Posted Mar 7 by John Deo

Aytu BioPharma's Return on Invested Capital (ROIC) is -18.15%, indicating inefficiency in using capital to ge

Source: Two Blokes Trading

Theriva Biologics, Inc. (AMEX:TOVX) Financial Analysis and Peer Comparison

Posted Mar 7 by John Deo

Theriva Biologics, Inc. (AMEX:TOVX) is a biotechnology company focused on developing innovative therapies for

Source: Two Blokes Trading

Neuronetics, Inc. (NASDAQ:STIM) Financial Efficiency Analysis

Posted Mar 7 by John Deo

Neuronetics, Inc. (NASDAQ:STIM) is a leading medical technology company that specializes in developing non-inv

Source: Two Blokes Trading

VersaBank's Financial Performance and Market Position

Posted Mar 6 by John Deo

Earnings Per Share (EPS) of $0.19 was reported, falling below the expected $0.29, marking a significant earni

Source: Two Blokes Trading

Thor Industries, Inc. (NYSE:THO) Faces Financial Challenges Amid Macroeconomic Headwinds

Posted Mar 6 by John Deo

Thor Industries, Inc. (NYSE:THO) reported an earnings per share (EPS) of -$0.058, missing estimates and indic

Source: Two Blokes Trading

Zscaler, Inc. (NASDAQ:ZS) Stock Analysis: A Look into the Future

Posted Mar 6 by John Deo

Mike Cikos from Needham sets a price target of $240 for ZS, indicating a potential increase of approximately

Source: Two Blokes Trading

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) Financial Challenges and Insights

Posted Mar 6 by John Deo

Earnings per Share (EPS) reported at -$0.64, missing the estimated EPS and indicating financial difficulties.

Source: Two Blokes Trading

MongoDB Stock Plunges 20% as Weak Full-Year Guidance Dims Strong Q4 Results

Posted Mar 6 by John Deo

MongoDB (NASDAQ:MDB) shares nosedived around 20% intra-day today, as investors reacted to the company’s disapp

Source: Two Blokes Trading

Marvell Plunges 17% as AI Growth Fails to Impress Investors

Posted Mar 6 by John Deo

Marvell Technology (NASDAQ:MRVL) saw its shares tumble over 17% intra-day on Thursday after delivering quarter

Source: Two Blokes Trading